A Prospective, Single-arm, Multicenter Study to Evaluate the Safety and Performance of the Instylla Hydrogel Embolic System (HES) For Patients Requiring Vascular Embolization Alone or in the Pre-operative Setting for Treatment of Malignant and Benign Hypervascular Tumors, and Select Non-Traumatic End-Organ Infarct.

Project: Research

StatusActive
Effective start/end date3/06/1931/12/24

Keywords

  • Vascular Embolization
  • Tumors
  • Clinical trial